Fundz

Lifespan Vision Ventures Invests In Bolden Therapeutics

PRIVATEJan 09, 2024

Round Type

Funding Round

ProvidenceBiotechnology

Investors

Life Span Vision Ventures

Description

LifeSpan Vision Ventures, an investment firm that specializes in funding longevity biotech breakthroughs, today announced an investment in Bolden Therapeutics, Inc. This biotechnology company is developing first-in-class therapeutics to promote neurogenesis for the potential treatment of central nervous system diseases.

Quick answer

Bolden Therapeutics raised an undisclosed amount in a Funding Round round, dated January 9, 2024. Investors: Life Span Vision Ventures. Bolden Therapeutics is based in Providence, Rhode Island, United States.

How much did Bolden Therapeutics raise?
Bolden Therapeutics raised an undisclosed amount in a Funding Round round on January 9, 2024.
Who invested in Bolden Therapeutics?
Life Span Vision Ventures is named as investors in this round.
What does Bolden Therapeutics do?
Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases such as Alzheimer’s and ischemic stroke.
Where is Bolden Therapeutics based and how big is it?
Bolden Therapeutics is based in Providence, Rhode Island, United States.
Who are the decision-makers at Bolden Therapeutics?
Fundz holds 1 contact at Bolden Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Bolden Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • DeepLook Medical raised $1.7M (Seed) on February 23, 2024.
  • Lumicell raised $2.3M (Seed) on February 22, 2024.
  • Simple Planet raised $6M (Series A) on February 22, 2024.
  • Frontier Medicines Corp raised $80M (Series C) on February 22, 2024.
  • Samphire Neuroscience raised $2.3M (Pre-Seed) on February 21, 2024.
  • INSAMO raised $12M (Seed) on February 21, 2024.

Who to call at Bolden Therapeutics, and when

A new round usually means Bolden Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Bolden Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Bolden Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Bolden Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Bolden Therapeutics

Location

Providence, Rhode Island, United States

About

Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases such as Alzheimer’s and ischemic stroke. The company’s scientific founders have identified a key molecular pathway to stimulate neural stem cells to promote the birth of new neurons (neurogenesis) in the adult brain. In a proprietary mouse model Bolden has established a proof-of-concept of this approach to increase neurogenesis and enhance hippocampal-dependent memory. The company is actively developing antisense oligonucleotide and monoclonal antibody therapeutics to modulate this pathway.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Bolden Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Bolden Therapeutics's next move

See what Strategic adds

Bolden Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.